Gynecological

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(Merck) MK-7902-001 / E7080-G000-313 / LEAP-001A Phase 3 Randomized, Open-Label, Study of Pembrolizumab (MK-3475) Plus Lenvatinib Versus Chemotherapy for First-line Treatment of Advanced or Recurrent Endometrial CarcinomaHirte, Dr HalOpen to recruitmentNCT03884101
Download PDF